PT  - JOURNAL ARTICLE
AU  - Bøstrand, Sunniva M. K.
AU  - Vaher, Kadi
AU  - De Nooij, Laura
AU  - Harris, Mathew A.
AU  - Cole, James H.
AU  - Cox, Simon R.
AU  - Marioni, Riccardo E.
AU  - McCartney, Daniel L.
AU  - Walker, Rosie M.
AU  - McIntosh, Andrew M.
AU  - Evans, Kathryn L.
AU  - Whalley, Heather C.
AU  - Wootton, Robyn E.
AU  - Clarke, Toni-Kim
TI  - Associations between alcohol use and accelerated biological ageing
AID  - 10.1101/2020.11.24.20237156
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.24.20237156
4099  - http://medrxiv.org/content/early/2020/11/25/2020.11.24.20237156.short
4100  - http://medrxiv.org/content/early/2020/11/25/2020.11.24.20237156.full
AB  - Background Harmful alcohol use is a leading cause of premature death, and is associated with age-related disease. Ageing is highly variable between individuals, and may deviate from chronological ageing, suggesting that biomarkers of biological ageing (based on DNA methylation or brain structural measures) may be clinically relevant. Here, we investigated the relationships between alcohol phenotypes and both brain and DNA methylation age estimates.Methods First, using data from UK Biobank and Generation Scotland, we tested the association between alcohol consumption (units/week) or hazardous use (AUDIT scores), and accelerated brain and epigenetic ageing in 20,258 and 8,051 individuals, respectively. Second, we used Mendelian randomization to test for a causal effect of alcohol consumption levels and alcohol use disorder (AUD) on biological ageing.Results Alcohol use showed a consistent positive association with higher predicted brain age (AUDIT-C: β=0.053, p=3.16×10−13; AUDIT-P: β=0.052, p=1.6×10−13; total AUDIT score: β=0.062, p=5.52×10−16; units/week: β=0.078, p=2.20×10−16), and DNA methylation GrimAge (Units/week: β=0.053, p=1.48×10− 7) and PhenoAge (Units/week: β=0.077, p=2.18×10−10). Mendelian randomization analyses revealed some evidence for a causal effect of AUD on accelerated brain ageing (β=0.272, p=0.044), and no evidence for a causal effect of alcohol consumption levels on accelerated biological ageing.Conclusions We provide consistent phenotypic evidence linking alcohol use with accelerated biological ageing. There is possible evidence for a causal effect of AUD on brain age, but not for any other alcohol-related trait on brain or epigenetic age acceleration. Future studies investigating the mechanisms associating alcohol use with accelerated biological ageing are warranted.Competing Interest StatementAMM reports grants from The Sackler Trust, grants from Eli Lilly, and grants from Janssen outside the submitted work. JHC is a shareholder in and scientific advisor to Brain Key, a medical image analysis software company. The remaining authors declare no conflicts of interest.Funding StatementThis work was supported by a Wellcome Trust Strategic Award 'Stratifying Resilience and Depression Longitudinally' (STRADL) [104036/Z/14/Z]. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. Genotyping of the GS:SFHS samples was funded by the Medical Research Council UK and the Wellcome Trust (Wellcome Trust Strategic Award (STRADL; Reference as above). DNA methylation profiling of the GS:SFHS samples was funded by the Wellcome Trust Strategic Award [10436/Z/14/Z] with additional funding from a 2018 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation [27404]. The UK Biobank core activities and imaging study was funded primarily by the Wellcome Trust and the Medical Research Council (MRC), as well as the Department of Health and the National Institute for Health Research (NIHR), the Scottish and Welsh Governments, the British Heart Foundation and Cancer Research UK. SMKB and KV are funded by the Wellcome Trust Translational Neuroscience PhD Programme at the University of Edinburgh [108890/Z/15/Z]. JHC is supported by a UKRI Innovation Fellowship (MR/R024790/2). SRC received support from the UK MRC [MR/R024065/1] and US National Institutes of Health [R01AG054628]. DLM and REM were supported by Alzheimer's Research UK Major Project grant (ARUK‐PG2017B‐10). REW works in a unit that receives funding from the University of Bristol and the UK Medical Research Council (MC_UU_00011/1 and MC_UU_00011/3).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:GS:SFHS has been granted ethical approval from the NHS Tayside Committee on Medical Research Ethics, on behalf of the National Health Service (reference: 05/S1401/89) and has Research Tissue Bank Status (reference: 15/ES/0040). UKB received ethical approval from the NHS National Research Ethics Service North West (reference:11/NW/0382). The present study was carried out under UKB project ID 4844.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAccording to the terms of consent for GS:SFHS, access to data must be reviewed by the GS Access Committee (access@generationscotland.org). Details concerning access to UK Biobank data can be found in the link provided. https://www.ukbiobank.ac.uk/principles-of-access/ Summary statistics from GWAS of AgeAccelPheno and AgeAccelGrim available here: https://datashare.is.ed.ac.uk/handle/10283/3645 Summary statistics from GWAS of brain age acceleration available here: https://datashare.is.ed.ac.uk/handle/10283/3797